Journal
AMERICAN JOURNAL OF HEMATOLOGY
Volume 81, Issue 1, Pages 36-44Publisher
WILEY
DOI: 10.1002/ajh.20490
Keywords
heparin; thrombocytopenia; thrombosis
Categories
Funding
- NHLBI NIH HHS [HL-13629, R01 HL013629] Funding Source: Medline
- NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [R37HL013629, R56HL013629, R01HL013629] Funding Source: NIH RePORTER
Ask authors/readers for more resources
Heparin, employed clinically for more than 50 years, is still a widely used anticoagulant. Unfortunately, some patients given this agent develop thrombocytopenia and thrombosis. Because this side effect can have catastrophic consequences, it is imperative that all clinicians caring for patients who receive heparin have at least a basic understanding of its pathogenesis, diagnosis, and management.
Authors
I am an author on this paper
Click your name to claim this paper and add it to your profile.
Reviews
Recommended
No Data Available